We are L-Proline CAS:147-85-3 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
A nonessential amino acid in human. It is synthesized from L-glutamine and L-glutamate via L-ornithine in intestine, and from L-ornithine in liver. It is widely used as an ingredient in infusion and infant formula.
|Specification||White crystals or crystalline powder, odorless or slightly characteristic odor, slightly sweet taste|
|STORAGE||Controlled room temperature in tight container|
SPECIFICATION AND PROCEDURE
| State of solution
|Not Less Than 98.0%|
|Ammonium (NH4)||Not More Than 0.020%|
|Chloride (Cl)||Not More Than 0.020%|
|Sulfate (SO4)||Not More Than 0.020%|
|Iron (Fe)||Not More Than 10 ppm|
|Heavy metals (Pb)**||Not More Than 10 ppm|
|Arsenic (As2O3)||Not More Than 1 ppm|
|Loss on drying||Not More Than 0.25%|
|Residue on ignition||Not More Than 0.10%|
|Endotoxin*||Less Than 6.0 EU/g|
|Assay (dry basis)||99.0～101.0%|
· * The endotoxin-certified grade will be supplied on request.
· ** FCC grade (Lead : Not More Than 5 mg/kg) will be supplied on request.
· This product meets requirements of residual solvents listed in the current JP, USP and EP.
Related News: Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies.(3R, 4S) -3-Hidroxi-4-fenilazetidin-2-ona CAS:132127-34-5 This is of vital important and underlies one of the most solid principles and regulations of modern pharmacy.2-cloro-3-fluoro-5-nitropiridina CAS:1079179-12-6 This is of vital important and underlies one of the most solid principles and regulations of modern pharmacy.zalcitabina CAS:7481-89-2 The main API products include antihypertensive, psychotropic and anti-AIDS special APIs. Antihypertensive APIs are mainly pulic and sartan drugs, and they are the world’s major suppliers of pulic and sartan APIs.Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.